This measure captures the proportion of ischemic or hemorrhagic stroke patients who received VTE prophylaxis or have documentation why no VTE prophylaxis was given on the day of or the day after hospital admission.
This measure is a part of a set of eight nationally implemented measures that address stroke care (STK-2: Discharged on Antithrombotic Therapy, STK-3: Anticoagulation Therapy for Atrial Fibrillation/Flutter, STK-4: Thrombolytic Therapy, STK-5: Antithrombotic Therapy By End of Hospital Day 2, STK-6 Discharged on Statin Medication, STK-8: Stroke Education, and STK-10: Assessed for Rehabilitation) that are used in The Joint Commission’s hospital accreditation and Disease-Specific Care certification programs.
- Measure TypeElectronic Clinical Quality Measure (eCQM)Care SettingNumerator
Ischemic or hemorrhagic stroke patients who received VTE prophylaxis or have documentation why no VTE prophylaxis was given on the day of or the day after hospital admission.
DenominatorIschemic or hemorrhagic stroke patients
Exclusions• Less than 18 years of age
• Length of Stay < 2 days
• Length of Stay > 120 days
• Comfort measures only documented on day of or day after hospital arrival
• Enrolled in clinical trials related to stroke
• Admitted for elective carotid interventionTesting Data Sources
- Measure StructureClinical Condition Topic AreaNon Condition SpecificTarget PopulationMeasure Selection AttributesNational Quality Strategy PrioritiesPatient Safety
- Risk Adjustment
- Current or planned use(s)Current Use(s)Use In Federal Program
- Most Recent Endorsement ActivityEndorsed with Reserve Status Neurology Project 2015-2016Initial EndorsementEndorsement StatusLast Updated
- StewardSteward Organization EmailSteward Organization Copyright
No royalty or use fee is required for copying or reprinting this manual, but the following are required as a condition of usage: 1) disclosure that the Specifications Manual is periodically updated, and that the version being copied or reprinted may not be up-to-date when used unless the copier or printer has verified the version to be up-to-date and affirms that, and 2) users participating in Joint Commission accreditation, including ORYX® vendors, are required to update their software and associated documentation based on the published manual production timelines.